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OBJECTIVES: Compliance with heart failure treatment
guidelines may improve quality of care and reduce health-
care utilization and costs. For accreditation purposes,
hospitals are required by the Joint Commission on the
Accreditation of Healthcare Organizations (JCAHO) to
measure performance for treatment of patients with heart
failure. The purpose of this study is to determine the effect
of hospital compliance with JCAHO performance 
measures and published guidelines on outcomes of
patients with heart failure (HF). METHODS: Thirty hos-
pitals submitted data on 1340 patients admitted with HF
between January 2, 2002 and March 30, 2002. The data
included patient demographics, HF severity, co-existing
illnesses, and type of medication therapy during hospi-
talization and at discharge. Univariate and multivariate
analyses such as ordinary least square (OLS) regression,
logistic regression, and Cox regression analyses were
applied. RESULTS: Current tobacco use and co-existing
illnesses such as cardiomyopathy and chronic renal
disease were signiﬁcantly associated with longer hospital
length of stay (LOS). Moreover, patients admitted to com-
munity hospitals had a lower inpatient mortality rate.
Patients receiving discharge instructions regarding follow-
up appointment and weight monitoring had signiﬁcantly
lower hospital LOS and mortality. Overall, patients
receiving treatment according to published guidelines 
had lower hospital LOS and inpatient mortality rate.
However, receiving treatment in hospitals with a care plan
for HF had no signiﬁcant impact on LOS or mortality.
CONCLUSIONS: Hospital compliance with JCAHO per-
formance measures and published guidelines is associated
with a signiﬁcant reduction in patient LOS or inpatient
mortality. However, patients treated in hospitals with a
care plan for heart failure had no signiﬁcant change in
LOS or mortality.
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OBJECTIVE: To demonstrate the bias inherent in using
categorical data for medication compliance assessments.
METHODS: Two datasets from studies in which patients
used electronic monitors (MEMS, AARDEX, Union City,
CA) to record long-term daily dosing were used for analy-
ses comparing categorical compliance (>50%, >60%,
>70%, >80%, >90%). Study A compared an intervention
to improve medication compliance with a usual care
control group in a study of Medication Usage Skills for
Effectiveness Program (MUSE-P) (Cramer, J Nerv Ment
Dis, 1999). Study B assessed compliance as a covariate 
to medication efﬁcacy (Krystal, Cramer, NEJM, 2001).
RESULTS: In Study A, analysis by categories of >50%,
>60%, >70%, >80%, and >90% compliance rates 
provided different results for the comparisons between
the intervention and control groups. The proportions of
Intervention and Control group patients who would have
been considered compliant were 90–87%, 85–71%,
77–61%, 64–34%, 54–24%, respectively by category.
Differences between the intervention and control groups
increased with higher standards of compliance (ratios
1.06, 1.22, 1.30, 1.92, 2.33). In Study B, decreasing pro-
portions of patients met criteria for compliance categories
(56%, 50%, 44%, 35%, 26%, respectively). Changing
categories affected regression models with the primary
outcome. CONCLUSIONS: This exercise demonstrated
the biases that occur when compliance is calculated by
category because of lack of information to support selec-
tion of a category designating appropriate compliance.
Information that would deﬁne a category below which 
a medication is ineffective is available for very few 
medications. Without such information, selection of a
category as a determinant of medication compliance is
inappropriate. This problem was removed by using 
continuous compliance data.
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OBJECTIVES: The literature contains a plethora of 
articles on medication compliance research, however, no
“gold standard” in the measurement of compliance has
been established. The Stage of Change (SOC) construct
measure from the Transtheoretical Model of behavioral
change has recently been validated in medication compli-
ance. The objective of this study is to compare the SOC
measure against Four other validated compliance mea-
sures in patients being treated for diabetes, hypertension,
hypercholesterolemia, hypothyroidism, and hormone
replace therapy. METHODS: A total of 171 male and
female patients in ﬁve primary care physician ofﬁces in
the state of Georgia, USA, completed a face-to-face ques-
tionnaire consisting of the SOC measure, the Medication
Adherence Scale, the Medication Outcomes Survey
(MOS) compliance question, the Brief Medication 
Compliance Questionnaire (BMQ) and sociodemo-
graphic information. Pharmacy reﬁll records (RR) were
collected as the ﬁfth compliance measure. RESULTS:
Pearson correlations ranged from a low of 0.09 between
RR and BMQ to a high of 0.79 between SOC and MOS.
All other correlations ranged between 0.20 and 0.49. All
correlations proved signiﬁcantly different than zero (p <
0.05) with the exception of the RR and BMQ correlation.
CONCLUSIONS: The majority of correlations between
validated measures of compliance ranged from weak to
moderate in strength. Therefore the results of this study
show selection of a useful compliance measure is difﬁcult.
The study ﬁndings emphasize that assessing medication-
taking behavior of patients and comparing the results of
different compliance studies is problematic. The develop-
